Merger Pending
Proposed Ignite Proteomics Inc. holding company and Ignite Proteomics merger
US$150m equity value
Announced 9 Jun 2026
Advisers
Ignite Proteomics
Target
Not disclosed
Proposed Ignite Proteomics Inc. holding company
Acquirer
Not disclosed
Other advisers
- Financial adviser
- Legal adviser
- Meister Seelig & Schuster PLLC
- Target
- Ignite Proteomics
- Acquirer
- Proposed Ignite Proteomics Inc. holding company
- Seller
- Aditxt
- Target based in
- United States (unverified)
- Buyer based in
- United States (unverified)
- Seller based in
- United States
- Sector
- Life Sciences
- Tags
- Life Sciences, Diagnostics, Oncology
In the league tables
Similar deals
- Tempus AI acquisition of Personalis Jul 2026 · US$1.9bn · Diagnostics
- CareDx acquisition of Naveris Apr 2026 · US$160m · Diagnostics
- Roche acquisition of SAGA Diagnostics Jun 2026 · US$595m · Diagnostics
- Perceptive Capital Solutions Corp and Freenome Holdings merger Dec 2025 · US$725m · Diagnostics
- Agilent Technologies acquisition of Biocare Medical Mar 2026 · US$950m · Diagnostics
Sources
- 10 Jun 2026 Press release (EX-99.1, exhibit), Aditxt Signed Definitive Agreement Valuing sec.gov